Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Youlu Lu"'
Autor:
Zhouting Tuo, Ying Zhang, Jinyou Wang, Huan Zhou, Youlu Lu, Xin Wang, Chao Yang, Dexin Yu, Liangkuan Bi
Publikováno v:
BMC Urology, Vol 21, Iss 1, Pp 1-10 (2021)
Abstract Background This study aimed to evaluate the effect of the three-port approach and conventional five-port laparoscopic radical cystectomy (LRC) with an ileal conduit. Methods Eighty-four patients, who were diagnosed with high-risk non-muscle-
Externí odkaz:
https://doaj.org/article/bcb9a60d31b5444ca57f796ef41976c9
Publikováno v:
Videosurgery and Other Miniinvasive Techniques, Vol 17, Iss 1, Pp 207-213 (2021)
Externí odkaz:
https://doaj.org/article/6e9f7553b05d4c4d98e1c2e10253d67d
Publikováno v:
Videosurgery and Other Miniinvasive Techniques, Vol 16, Iss 4, Pp 715-721 (2021)
Externí odkaz:
https://doaj.org/article/5a90b52187334d60aad86f51e83193cf
Publikováno v:
Videosurgery & Other Miniinvasive Techniques / Wideochirurgia i Inne Techniki Mało Inwazyjne. 2022, Vol. 17 Issue 1, p207-213. 7p.
Autor:
Jiahao Shan, Xinyu Geng, Youlu Lu, Ziyang Liu, Hengyu Zhu, Raorao Zhou, Zhengyuan Zhang, Xianghui Gang, Duobing Zhang, Hongbin Shi
Publikováno v:
Journal of Clinical Laboratory Analysis. 36
The purpose of the study was to evaluate the diagnostic significance of two new and a few clinical markers for prostate cancer (PCa) at various prostate volumes (PV).The study subjects were divided into two groups. Among them, there were 70 cases in
Autor:
Jiahao Shan, Xinyu Geng, Ziyang Liu, Youlu Lu, Raorao Zhou, Zhengyuan Zhang, Haoran Xu, Xiaojie Zhou, Wenzhuo Ma, Hengyu Zhu, Hongbin Shi
Publikováno v:
Andrologia. 54
This study aimed to analyse the clinical characteristics and risk factors of patients with positive prostate biopsy at 4-20 ng/mL of prostate-specific antigen (PSA), construct a new parameter based on this characteristics and assess its diagnostic va
Autor:
Longfei Peng, Ying Zhang, Youlu Lu, Dexin Yu, Liangkuan Bi, Zhouting Tuo, Huan Zhou, Xin Wang, Zhangjun Cao
Publikováno v:
Oncology Reports
Renal cell carcinoma (RCC) is a lethal urologic tumor commonly seen in men that best responds to partial nephrectomy. An enhanced understanding of the molecular pathogenesis of RCC can broaden treatment options and tumor prevention strategies. Sirtui
Autor:
Dexin Yu, Ci Zou, Weiwei Qian, Dengdian Wang, Liangkuan Bi, Dongdong Xie, Hao Geng, Lei Chen, Xin Wang, Hongliang Sun, Yi Wang, Youlu Lu, Caiyun Zhong, Yuan Li
Publikováno v:
Oncology Letters
Substantial evidence suggests that cancer stem cells (CSCs) are the main cause of the initiation, progression and recurrence of tumors. Benzidine has been identified as a risk factor for bladder cancer. The aim of the present study was to investigate
Publikováno v:
Andrologia. 52
There have been some conflicting claims whether larger prostate weight (PW) reduces the risk of positive surgical margins (PSMs). This study aims to examine the associations between PW and PSMs. PubMed, Web of Science and Cochrane library were system
Publikováno v:
Expert review of anticancer therapy. 19(7)
Background: Qualitative and quantitative analysis of circulating cell-free DNA (cfDNA) is a potential detection method for bladder cancer. Many studies have focused on the reliability of these results, but the conclusions have not been consistent. Me